SPRC ▼ -3.0% - SciSparc Ltd.
$SPRC - SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
22-OCT-2026 08:55 AM ET
Share this post
More filings for $SPRC
SPRC ▼ -1.2% - SciSparc Ltd.Oct 19, 2026SPRC ▼ -44.1% - SciSparc Ltd.Oct 15, 2026SPRC ▲ +32.8% - SciSparc Ltd.Oct 15, 2026SPRC ▲ +26.4% - SciSparc Ltd.Oct 15, 2026SPRC ▲ +1.8% - SciSparc Ltd.Oct 7, 2026SPRC ▲ +1.5% - SciSparc Ltd.Sep 23, 2026
View full $SPRC filing history →💬 Comments
Loading comments…
Leave a comment